Evidence map›Paper›PMID 35618743›Full record

ReviewNPJ biofilms and microbiomes2022

Economic significance of biofilms: a multidisciplinary and cross-sectoral challenge.

Miguel Cámara, William Green, Cait E MacPhee, Paulina D Rakowska, Rasmita Raval, Mark C Richardson, Joanne Slater-Jefferies, Katerina Steventon, Jeremy S Webb

Abstract readReview
In one paragraph

Review in NPJ biofilms and microbiomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 129 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Molecular imaging of bacterial biofilms-a systematic review.Critical reviews in microbiology · 2024
    Pooled it
  2. Article
  3. Beyond Bactericidal: Plasma Surface Engineering to Defeat Food Matrix-Conditioning Layers.Comprehensive reviews in food science and food safety · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miguel CámaraNational Biofilms Innovation Centre, University of Nottingham Biodiscovery Institute, School of Life Sciences, University of Nottingham, Nottingham, UK. Miguel.Camara@nottingham.ac.uk.ORCID 0000-0003-4585-7385
William GreenNational Biofilms Innovation Centre, School of Biological Sciences, University of Southampton, Southampton, UK.
Cait E MacPheeNational Biofilms Innovation Centre, School of Physics and Astronomy, University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-8313-8387
Paulina D RakowskaNational Biofilms Innovation Centre, School of Biological Sciences, University of Southampton, Southampton, UK.ORCID 0000-0002-3710-8395
Rasmita RavalNational Biofilms Innovation Centre, UK & Open Innovation Hub for Antimicrobial Surfaces, Department of Chemistry, University of Liverpool, Liverpool, UK.
Mark C RichardsonNational Biofilms Innovation Centre, School of Biological Sciences, University of Southampton, Southampton, UK.
Joanne Slater-JefferiesNational Biofilms Innovation Centre & School of Biological Sciences, University of Southampton, Southampton, UK.ORCID 0000-0001-8325-1320
Katerina SteventonNational Biofilms Innovation Centre, School of Biological Sciences, University of Southampton, Southampton, UK.
Jeremy S WebbNational Biofilms Innovation Centre & School of Biological Sciences, University of Southampton, Southampton, UK.ORCID 0000-0003-2068-8589

Funding

Biotechnology and Biological Sciences Research Council BB/R012415/1
6 · The paper itself

Abstract

The increasing awareness of the significance of microbial biofilms across different sectors is continuously revealing new areas of opportunity in the development of innovative technologies in translational research, which can address their detrimental effects, as well as exploit their benefits. Due to the extent of sectors affected by microbial biofilms, capturing their real financial impact has been difficult. This perspective highlights this impact globally, based on figures identified in a recent in-depth market analysis commissioned by the UK's National Biofilms Innovation Centre (NBIC). The outputs from this analysis and the workshops organised by NBIC on its research strategic themes have revealed the breath of opportunities for translational research in microbial biofilms. However, there are still many outstanding scientific and technological challenges which must be addressed in order to catalyse these opportunities. This perspective discusses some of these challenges.

Indexed as

Biofilms

Identifiers

PMID35618743
PMCPMC9135682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.